Lentiviral Diseases: EIAV Pathogenesis

Information

  • Research Project
  • 7674877
  • ApplicationId
    7674877
  • Core Project Number
    R01CA059278
  • Full Project Number
    3R01CA059278-12S1
  • Serial Number
    59278
  • FOA Number
  • Sub Project Id
  • Project Start Date
    3/1/1993 - 31 years ago
  • Project End Date
    7/31/2011 - 12 years ago
  • Program Officer Name
    OGUNBIYI, PETER
  • Budget Start Date
    8/21/2008 - 15 years ago
  • Budget End Date
    7/31/2009 - 14 years ago
  • Fiscal Year
    2008
  • Support Year
    12
  • Suffix
    S1
  • Award Notice Date
    8/20/2008 - 15 years ago

Lentiviral Diseases: EIAV Pathogenesis

[unreadable] DESCRIPTION (provided by applicant): We have investigated virulence determinants of equine infectious anemia virus (EIAV), a macrophage-tropic lentivirus, and have shown that both the surface glycoprotein (SU) and the auxiliary protein, S2, significantly influence disease expression. Based on preliminary studies we hypothesize that (1) A virulent EIAV strain, through the activities of its SU and S2 proteins, modulates host cell gene expression; (2) Modified gene expression alters host cell physiology, generating an environment optimally suited to high titer virus replication and disease expression. Specific Aims of the proposal are: AIM 1. Characterize changes in gene expression induced by acutely virulent EIAV and its SU protein. We will: (i) Measure induction of cytokine and chemokine gene expression by virulent EIAV and purified SU in relevant equine cells, (ii) Map the regions of SU responsible for modulation of cytokine/chemokine gene expression using chimeric viruses and recombinant SU proteins, (iii) Test sub-regions of SU for their contribution to the development of acute disease in a Shetland pony model. AIM 2. We will characterize the properties of the EIAV S2 protein using both in vivo and in vitro assays by site-directed mutagenesis of predicted functional domains. The results obtained from our in vivo acute pathogenesis assay with site-specific virus mutants will serve to guide our in vitro studies that are directed at (i) identifying cellular proteins that interact with the S2 protein and (ii) the characterization of in vitro biologic activities attributable to the S2 protein. Animal studies related to Aims 1 and 2 will include determination of platelet counts, plasma virus loads, provirus levels in circulating PBMC and in tissues, cytokine/chemokine gene expression in circulating PBMC and tissues, and viral gene expression in PBMC and tissues. As EIAV replication and persistence are centered on monocytes/macrophages, and disease expression is rapid (2-3 weeks), this model is ideal for specifically probing the interactions of virus and macrophages that contribute to lentiviral-induced disease. [unreadable] [unreadable] [unreadable]

IC Name
NATIONAL CANCER INSTITUTE
  • Activity
    R01
  • Administering IC
    CA
  • Application Type
    3
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    53524
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    393
  • Ed Inst. Type
    SCHOOLS OF VETERINARY MEDICINE
  • Funding ICs
    NCI:53524\
  • Funding Mechanism
  • Study Section
    AIP
  • Study Section Name
    AIDS Immunology and Pathogenesis Study Section
  • Organization Name
    TEXAS A&M UNIVERSITY SYSTEM
  • Organization Department
    VETERINARY SCIENCES
  • Organization DUNS
    047006379
  • Organization City
    COLLEGE STATION
  • Organization State
    TX
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    77845
  • Organization District
    UNITED STATES